De santis, Maria
 Distribuzione geografica
Continente #
NA - Nord America 5.812
AS - Asia 3.770
EU - Europa 1.458
AF - Africa 729
SA - Sud America 720
Continente sconosciuto - Info sul continente non disponibili 139
OC - Oceania 7
Totale 12.635
Nazione #
US - Stati Uniti d'America 5.656
SG - Singapore 2.222
CN - Cina 728
SC - Seychelles 611
BR - Brasile 591
IT - Italia 416
VN - Vietnam 342
FI - Finlandia 226
IE - Irlanda 157
DE - Germania 133
HK - Hong Kong 113
FR - Francia 101
IN - India 95
GB - Regno Unito 89
CA - Canada 79
NL - Olanda 64
AR - Argentina 51
MX - Messico 45
NG - Nigeria 45
RU - Federazione Russa 43
BD - Bangladesh 37
SE - Svezia 37
PL - Polonia 32
ZA - Sudafrica 30
IQ - Iraq 26
ID - Indonesia 24
CZ - Repubblica Ceca 23
EC - Ecuador 21
TR - Turchia 21
MK - Macedonia 20
JP - Giappone 19
CO - Colombia 18
ES - Italia 18
BE - Belgio 16
PH - Filippine 15
PK - Pakistan 15
CL - Cile 13
SA - Arabia Saudita 13
UA - Ucraina 12
UZ - Uzbekistan 12
IL - Israele 11
AT - Austria 10
JO - Giordania 9
IR - Iran 8
LT - Lituania 8
MY - Malesia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
JM - Giamaica 7
MA - Marocco 7
NP - Nepal 7
TN - Tunisia 7
AU - Australia 6
EG - Egitto 6
KR - Corea 6
PE - Perù 6
AL - Albania 5
AM - Armenia 5
DZ - Algeria 5
LB - Libano 5
PT - Portogallo 5
PY - Paraguay 5
BG - Bulgaria 4
HN - Honduras 4
KE - Kenya 4
KG - Kirghizistan 4
SN - Senegal 4
UY - Uruguay 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
HR - Croazia 3
KZ - Kazakistan 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
BW - Botswana 2
CR - Costa Rica 2
DM - Dominica 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
QA - Qatar 2
UG - Uganda 2
BQ - ???statistics.table.value.countryCode.BQ??? 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
Totale 12.477
Città #
Singapore 944
Chandler 665
Ashburn 624
San Jose 572
Dallas 535
The Dalles 337
Shanghai 265
Council Bluffs 243
Helsinki 225
New York 209
Boardman 189
Wilmington 181
Los Angeles 167
Beijing 161
Dublin 157
Milan 120
Ho Chi Minh City 110
Santa Clara 109
Hong Kong 100
Hanoi 85
San Mateo 77
Paris 60
São Paulo 51
Amsterdam 47
Ann Arbor 47
Phoenix 45
Sassari 45
Buffalo 42
Benin City 41
London 40
Rome 40
Princeton 37
Lawrence 35
Naples 35
Assago 32
Leawood 31
Pune 29
Falkenstein 28
Seattle 26
Warsaw 26
Chennai 23
Toronto 23
Woodbridge 21
Columbus 20
Boston 19
Brno 19
Da Nang 19
Mexico City 19
Chicago 18
Munich 18
Orem 18
Charlotte 17
Montreal 17
Belo Horizonte 16
Brussels 16
Frankfurt am Main 16
San Francisco 16
Haiphong 15
Brooklyn 14
Curitiba 14
Fairfield 13
Houston 13
San Diego 13
Stockholm 13
Johannesburg 12
Moscow 12
Rio de Janeiro 12
Tokyo 12
Figino 11
Tashkent 11
Brasília 10
Buenos Aires 9
Dhaka 9
Porto Alegre 9
Skopje 9
Atlanta 8
Pasadena 8
Quito 8
Amman 7
Aurora 7
Baghdad 7
Bogotá 7
Denver 7
Goiânia 7
Guayaquil 7
Istanbul 7
Jakarta 7
Manchester 7
Mumbai 7
New Delhi 7
Orlando 7
Hangzhou 6
Jeddah 6
Kocaeli 6
Miami 6
Ottawa 6
Bari 5
Bitola 5
Biên Hòa 5
Bến Tre 5
Totale 7.503
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 700
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 225
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 158
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 145
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 131
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 129
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 123
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 121
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 120
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 120
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 118
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 116
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 115
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 113
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 111
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 111
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 109
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 104
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 103
5 reasons to encourage anti-SARS-CoV-2 vaccination in patients with rheumatic diseases 103
Liver involvement in subjects with rheumatic disease 100
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 98
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 98
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 97
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 93
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies 92
Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study' 92
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 92
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 91
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 90
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 89
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis 88
Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis 87
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 87
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 84
Liver abnormalities in connective tissue diseases 84
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 84
The role of Wnt pathway in the pathogenesis of OA and its potential therapeutic implications in the field of regenerative medicine 81
Analysis of interstitial lung involvement in a cohort of 100 patients with systemic sclerosis. Prevalence of alveolitis detected by bronchoalveolar lavage and HRCT 80
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. 80
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 80
T-Cell response to carbamylated and citrullinated collagen epitopes in patients with rheumatoid arthritis carrying DRβ1*04 79
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 78
Autoantibodies and organ involvement in systemic sclerosis 78
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 77
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 76
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 76
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 76
B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial 75
DRESS syndrome in response to Denosumab: First documented case report 75
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 74
Artriti infettive 73
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 73
Type III interferons disrupt the lung epithelial barrier upon viral recognition 72
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 72
B cell depletion and a T cell-targeted therapy allows to control the sudden onset of diabetes and lupus, without steroids 72
Gastrointestinal symptoms and nutritional profile during pregnancy 71
Viral Respiratory Pathogens and Lung Injury 71
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 71
Digital ulcers predict a worse disease course in patients with systemic sclerosis 70
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 69
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 69
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 68
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 68
The elegance of a macrophage 68
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients 68
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis 68
Cancer in connective tissue disease 67
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 66
CD19+ cells subsets (CD5, CD38 and CD23) in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with disease activity and with auto-antibody levels 66
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 66
Add-on rituximab for primary heart involvement associated with systemic sclerosis: A step forward in the tailored treatment of myocarditis? 66
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 66
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 65
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: A report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group 64
The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies 64
La sclerodermia 63
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine 63
BAFF and rheumatic autoimmune disorders: implications for disease management and therapy 63
How advances in personalized medicine will change rheumatology 63
Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis 62
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate 62
The therapeutic potential of epigenetics in autoimmune diseases 62
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 62
Pharmacogenetics/pharmacogenomics and antirheumatic drugs in rheumatology 61
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis 61
Tumori ossei 61
B-cell directed therapy in rheumatoid arthritis: predictive factors of efficacy and assessment of regeneration profile 60
The autoinflammatory side of systemic sclerosis 60
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 60
The genetic bases of asthma 59
Tumor necrosis factor-alpha inhibitor therapy in erosive polyarthritis secondary to systemic sclerosis 59
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 58
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature 58
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 58
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum 57
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 56
Mapping and predicting mortality from systemic sclerosis 56
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 55
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database 55
Totale 8.853
Categoria #
all - tutte 73.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022179 0 2 3 42 1 0 9 29 10 17 42 24
2022/20231.630 102 102 152 222 118 150 5 193 289 143 129 25
2023/20241.290 105 102 272 106 35 175 82 33 21 42 80 237
2024/20252.603 51 24 624 43 62 258 159 143 333 460 241 205
2025/20265.837 802 293 618 481 234 261 1.440 269 292 337 370 440
2026/2027721 356 365 0 0 0 0 0 0 0 0 0 0
Totale 12.635